Antiretroviral News and Research

RSS

Viewpoints: Progressives relish fight for 'shared sacrifice;' Desmond Tutu seeks to renew battle against HIV

To get our books in order, Obama would raise taxes on the rich while gaining savings by ending the wars abroad and reducing Medicare and Medicaid's unnecessarily high payments to drug companies. Republicans rise in defense of tax cuts for the wealthy and insist that deficit reduction come solely from cuts in Social Security, Medicare and Medicaid and other "entitlements." The president stands for shared sacrifice; the Republicans for sheltering the privileged few. Progressives will have no problem standing with the president in this fight.

22 Sep 2011

Gilead’s Quad Phase 3 clinical study in treatment-naïve HIV-1 patients meets 48-week primary objective

Gilead Sciences, Inc. today announced that the second pivotal Phase 3 clinical trial of its investigational fixed-dose, single-tablet "Quad" regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate, being evaluated for HIV-1 infection in treatment-naïve patients, met its primary objective of non-inferiority at week 48 as compared to ritonavir-boosted atazanavir plus Truvada.

20 Sep 2011

Online gamers decipher 3D molecular structure that may help AIDS research

Online gamers have deciphered the structure of an enzyme of an AIDS-like virus that had thwarted scientists for a decade. The exploit was published in the journal, Nature Structural & Molecular Biology, where - exceptionally in scientific publishing - both gamers and researchers are honored as co-authors.

19 Sep 2011

Infrared Systems International is now AquaLiv Technologies

Infrared Systems International announced it has changed its name to AquaLiv Technologies, Inc. in order to better reflect its new corporate strategy. Along with the name change the company has been issued a new symbol by FINRA of AQLV.

17 Sep 2011

PopART project awarded $37 million study grant for HIV prevention in Africa

A team of researchers led by Professor Richard Hayes at the London School of Hygiene and Tropical Medicine has been awarded $37 million to test an innovative combination of strategies to prevent HIV in African countries.

16 Sep 2011

U.S. HIV/AIDS policy and funding should be guided by science, policy statement recommends

The IDSA Center for Global Health Policy and the HIV Medicine Association recently released a policy statement responding to the results of the HPTN 052 study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) at NIH, which found that people with HIV who received immediate antiretroviral therapy (ART) were more than 96 percent less likely to sexually transmit the infection to their uninfected partners.

16 Sep 2011

Indian state of Jammu and Kashmir avoids grim AIDS predictions

When the only community health care center providing medical and psychosocial care for people living with HIV/AIDS in India's northernmost state of Jammu and Kashmir "closed down six months ago for lack of patients, it was a sure sign that the north Indian state had beaten back dire forecasts," Inter Press Service reports.

14 Sep 2011

Rwanda to treat HIV-positive people in discordant relationships as soon as they test positive

After a landmark study published in May "showed major reductions in HIV transmission among discordant couples due to early treatment," Rwanda has decided to begin treating people in discordant relationships with antiretroviral therapy as soon as they test HIV-positive "as part of a plan to boost national HIV prevention and treatment efforts," PlusNews reports.

14 Sep 2011

Einstein led consortium to spearhead Central Africa International Epidemiologic Databases to Evaluate AIDS

In 2004, the global community acted in earnest to address the HIV/AIDS epidemic in Africa. As a result, millions of Africans are now receiving the same advanced antiretroviral therapy (ART) that has long been available in the developed world. While research shows that AIDS death rates in Africa have stabilized, little is known about the actual deployment and circumstances of treatment.

9 Sep 2011

Dwindling donor funding in Burundi leads to national shortage of ARVs

"Burundian NGOs say at least 20 people have died" as a result of a "months-long shortage" of antiretroviral drugs (ARVs), although "Ministry of Health officials could not be reached to confirm the number of people affected," PlusNews reports.

7 Sep 2011

WHO African region member states have challenges to meet MDGs, WHO/AFRO Director says

Speaking at the 61st session of the WHO Regional Office for Africa (AFRO) in Yamoussoukro, Cote d'Ivoire, on Thursday, African Regional Director of WHO Luis Sambo said "that 46 Africa member countries still had remarkable challenges to scale before meeting the United Nations Millennium Development Goals (MDGs)," Nigeria's The Nation reports.

3 Sep 2011

'Sustainable global pharmacovigilance' systems needed to monitor ARVs, other drugs

With more widespread access to antiretroviral (ARV) drugs comes a greater need to monitor and promote the safety and effectiveness of these essential medicines in the new environments, which are distinct from those of pre-market studies and the resource rich countries that have had ARV access for years.

2 Sep 2011

IPS examines DNDi program to develop pediatric HIV drugs

Inter Press Service profiles a program launched by the Drugs for Neglected Diseases Initiative (DNDi) to develop antiretroviral drugs (ARVs) specifically designed for children living with HIV/AIDS.

31 Aug 2011

Cost of second-line ARVs a 'huge barrier to care' in resource-poor countries

In this U.N. Dispatch blog post, Mark Leon Goldberg, managing editor of the blog, examines the costs of second-line antiretroviral treatments (ARVs), which "are several orders of magnitude more expensive than traditional, first-line ARV treatments" and are a "huge barrier to providing care" for resource-poor countries.

31 Aug 2011

Symptom-based viral load testing detects HIV in MSM

Testing for HIV when flu-like symptoms develop may offer a cost-effective alternative for early detection of HIV infection in men who have sex with men (MSM), reports a study in the journal AIDS.

31 Aug 2011

Infrared Systems completes several internal projects, discusses corporate strategies

Infrared Systems International announces the completion of several internal projects and discusses corporate strategies for continued success.

29 Aug 2011

Asia-pacific region making gains against HIV/AIDS, but more needs to be done, UNAIDS report says

...

26 Aug 2011

AHF shares The Lancet's concerns over use of Gilead's Truvada as HIV prevention pill

Today AIDS Healthcare Foundation (AHF) commented on an editorial published in the September 2011 issue of The Lancet Infectious Diseases that raises concerns about the use of the HIV treatment drug Truvada, manufactured by Gilead Sciences Inc., as an HIV prevention pill or pre-exposure prophylaxis (PrEP), agreeing with the publication's public health concerns.

25 Aug 2011

IRIN reports on HIV-positive Kenyans' struggle to reach food aid

IRIN reports on the difficulties some people living with HIV in Kenya face in accessing food. "Partly because of a prolonged dry spell, some 3.6 million Kenyans need emergency food assistance," and, while there is food aid available in Kenya, poor roads prevent the aid from reaching some villages, according to IRIN.

25 Aug 2011

HIV-positive pregnant women across Africa face discrimination

HIV-positive women across Africa are facing discrimination, with many "say[ing] they have been pressured – even forced – not to have children because people assume they will infect their babies," PRI's The World reports. "Across the continent, there have been organized efforts to prevent HIV-positive women from having children," The World writes, referencing family planning programs aimed at HIV-positive women in Kenya, Namibia and Uganda.

24 Aug 2011

Antiretroviral News and Research

Viewpoints: Progressives relish fight for 'shared sacrifice;' Desmond Tutu seeks to renew battle against HIV

Gilead’s Quad Phase 3 clinical study in treatment-naïve HIV-1 patients meets 48-week primary objective

Online gamers decipher 3D molecular structure that may help AIDS research

Infrared Systems International is now AquaLiv Technologies

PopART project awarded $37 million study grant for HIV prevention in Africa

U.S. HIV/AIDS policy and funding should be guided by science, policy statement recommends

Indian state of Jammu and Kashmir avoids grim AIDS predictions

Rwanda to treat HIV-positive people in discordant relationships as soon as they test positive

Einstein led consortium to spearhead Central Africa International Epidemiologic Databases to Evaluate AIDS

Dwindling donor funding in Burundi leads to national shortage of ARVs

WHO African region member states have challenges to meet MDGs, WHO/AFRO Director says

'Sustainable global pharmacovigilance' systems needed to monitor ARVs, other drugs

IPS examines DNDi program to develop pediatric HIV drugs

Cost of second-line ARVs a 'huge barrier to care' in resource-poor countries

Symptom-based viral load testing detects HIV in MSM

Infrared Systems completes several internal projects, discusses corporate strategies

Asia-pacific region making gains against HIV/AIDS, but more needs to be done, UNAIDS report says

AHF shares The Lancet's concerns over use of Gilead's Truvada as HIV prevention pill

IRIN reports on HIV-positive Kenyans' struggle to reach food aid

HIV-positive pregnant women across Africa face discrimination

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News